PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14984736-9	2004	When HEK-293 cells expressed either PLD1 or PLD2, we observed elevated p38 phosphorylation in response to TPA stimulation.	Tetradecanoylphorbol Acetate	106-109	phospholipase D1	Homo sapiens	36-40	
15591778-5	2004	Both ACh and PMA increased phosphorylation of PLD1 that was significantly blocked by genistein or the PKC inhibitor calphostin C.	Tetradecanoylphorbol Acetate	13-16	phospholipase D1	Homo sapiens	46-50	
15591778-7	2004	Western blots probed with an anti-phosphotyrosine antibody indicate that PLD1 in this tissue is phosphorylated on tyrosine residues after ACh or PMA stimulation.	Tetradecanoylphorbol Acetate	145-148	phospholipase D1	Homo sapiens	73-77	
15020229-3	2004	Retinoic acid (RA)-induced differentiation increased PLD1 and PLD2 mRNA levels and PLD activity that was responsive to phorbol myristate acetate.	Tetradecanoylphorbol Acetate	119-144	phospholipase D1	Homo sapiens	53-57	
16716806-0	2006	Se-methylselenocysteine enhances PMA-mediated CD11c expression via phospholipase D1 activation in U937 cells.	Tetradecanoylphorbol Acetate	33-36	phospholipase D1	Homo sapiens	67-83	
16045763-3	2005	We sought to identify proteins that interact with PLD1 after phorbol 12-myristate 13-acetate (PMA) stimulation.	Tetradecanoylphorbol Acetate	61-92	phospholipase D1	Homo sapiens	50-54	
16045763-3	2005	We sought to identify proteins that interact with PLD1 after phorbol 12-myristate 13-acetate (PMA) stimulation.	Tetradecanoylphorbol Acetate	94-97	phospholipase D1	Homo sapiens	50-54	
11485559-8	2001	Consistent with PLD1 up-regulation was the observation that PLD enzymic activity was higher in monocytes treated with active-pathogen-derived agonists than in control cells, when stimulated with PMA or with chemotactic agonists (fMet-Leu-Phe and C5a).	Tetradecanoylphorbol Acetate	195-198	phospholipase D1	Homo sapiens	16-20	
14596936-2	2003	12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced PLD1 activation was suppressed by the introduction of PKCdelta as well as its kinase-negative mutant in MeWo cells, which contain PKCalpha but lack PKCbeta.	Tetradecanoylphorbol Acetate	0-36	phospholipase D1	Homo sapiens	51-55	
14596936-2	2003	12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced PLD1 activation was suppressed by the introduction of PKCdelta as well as its kinase-negative mutant in MeWo cells, which contain PKCalpha but lack PKCbeta.	Tetradecanoylphorbol Acetate	38-41	phospholipase D1	Homo sapiens	51-55	
14596936-4	2003	In MeWo cells introduced by PKCalpha and PLD1, the association of these proteins was observed, which was enhanced by the TPA treatment.	Tetradecanoylphorbol Acetate	121-124	phospholipase D1	Homo sapiens	41-45	
14596936-5	2003	In cells overexpressing PKCdelta in addition to PKCalpha and PLD1, TPA treatment increased the association of PKCdelta and PLD1, while it attenuated the association of PKCalpha and PLD1.	Tetradecanoylphorbol Acetate	67-70	phospholipase D1	Homo sapiens	61-65	
14596936-5	2003	In cells overexpressing PKCdelta in addition to PKCalpha and PLD1, TPA treatment increased the association of PKCdelta and PLD1, while it attenuated the association of PKCalpha and PLD1.	Tetradecanoylphorbol Acetate	67-70	phospholipase D1	Homo sapiens	123-127	
14596936-5	2003	In cells overexpressing PKCdelta in addition to PKCalpha and PLD1, TPA treatment increased the association of PKCdelta and PLD1, while it attenuated the association of PKCalpha and PLD1.	Tetradecanoylphorbol Acetate	67-70	phospholipase D1	Homo sapiens	123-127	
14596936-6	2003	These results indicate that PKCdelta inhibits TPA-induced PLD1 activation mediated by PKCalpha through the association with PLD1.	Tetradecanoylphorbol Acetate	46-49	phospholipase D1	Homo sapiens	58-62	
14596936-6	2003	These results indicate that PKCdelta inhibits TPA-induced PLD1 activation mediated by PKCalpha through the association with PLD1.	Tetradecanoylphorbol Acetate	46-49	phospholipase D1	Homo sapiens	124-128	
12074591-6	2002	Furthermore, the TPA treatment increased the association of PKCalpha, PKCbetaII, and their kinase-negative mutants with PLD1 in melanoma cells.	Tetradecanoylphorbol Acetate	17-20	phospholipase D1	Homo sapiens	120-124	
32074974-8	2020	These results present a novel mechanism showing that CTR-GNPs can attenuate the migration and invasion of glioblastoma cells induced by PMA through transcriptional and translational regulation of MMP-2/-9 and PLD1.	Tetradecanoylphorbol Acetate	136-139	phospholipase D1	Homo sapiens	209-213	
11734063-9	2001	Overexpression of human PLD1 by transient transfection increased PLD activity by 4.6-fold and ACh synthesis by 2.3-fold in the presence of PMA as compared to controls.	Tetradecanoylphorbol Acetate	139-142	phospholipase D1	Homo sapiens	24-28	
10802049-5	2000	Moreover, bradykinin (BK), thrombin and phorbol 12-myristate 13-acetate induced rapid stimulation of PLD activity in CELMs.	Tetradecanoylphorbol Acetate	40-71	phospholipase D1	Homo sapiens	101-104